Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Common disorders are quantitative traits

A Corrigendum to this article was published on 09 November 2009

This article has been updated

Abstract

After drifting apart for 100 years, the two worlds of genetics — quantitative genetics and molecular genetics — are finally coming together in genome-wide association (GWA) research, which shows that the heritability of complex traits and common disorders is due to multiple genes of small effect size. We highlight a polygenic framework, supported by recent GWA research, in which qualitative disorders can be interpreted simply as being the extremes of quantitative dimensions. Research that focuses on quantitative traits — including the low and high ends of normal distributions — could have far-reaching implications for the diagnosis, treatment and prevention of the problematic extremes of these traits.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Change history

  • 06 November 2009

    An incorrect version of this article was previously published online (publication date 27 October 2009). In the second paragraph of the 'Identifying quantitative mechanisms' section in this article, the history of genome-wide association (GWA) studies for type 2 diabetes was incorrectly described and a key reference was omitted. The corrected paragraph is shown below. The authors apologize for this error. For some traits, such as type 2 diabetes (T2D), a quantitative approach has already been embraced, with striking results9. Although the first T2D GWA studies were case–control studies (REF. 49, and subsequently other studies, for example, REF. 3), a wave of follow-up studies have focused on quantitative traits that are related to T2D, including levels of fasting glucose10 and C-reactive protein11, and glucose tolerance9. These studies are leading to refinements in the definition of T2D. Reference 49 has now been added to the reference list.

References

  1. Fisher, R. A. The correlation between relatives on the supposition of Mendelian inheritance. Trans. R. Soc. Edinb. 52, 399–433 (1918).

    Article  Google Scholar 

  2. Donnelly, P. Progress and challenges in genome-wide association studies in humans. Nature 456, 728–731 (2008).

    Article  CAS  Google Scholar 

  3. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).

  4. Maher, B. Personal genomes: the case of the missing heritability. Nature 456, 18–21 (2008).

    Article  CAS  Google Scholar 

  5. Falconer, D. S. & MacKay, T. F. C. Introduction to Quantitative Genetics (Longman, Harlow, 1996).

    Google Scholar 

  6. Kruglyak, L. The road to genome-wide association studies. Nature Rev. Genet. 9, 314–318 (2008).

    Article  CAS  Google Scholar 

  7. McCarthy, M. I. et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Rev. Genet. 9, 356–369 (2008).

    Article  CAS  Google Scholar 

  8. MacKay, T. F. C., Stone, E. A. & Ayroles, J. F. The genetics of quantitative traits: challenges and prospects. Nature Rev. Genet. 10, 565–577 (2009).

    Article  CAS  Google Scholar 

  9. Rung, J. et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nature Genet. 41, 1110–1115 (2009).

    Article  CAS  Google Scholar 

  10. Bouatia-Naji, N. et al. A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 320, 1085–1088 (2008).

    Article  CAS  Google Scholar 

  11. Elliott, P. et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302, 37–48 (2009).

    Article  CAS  Google Scholar 

  12. Podolsky, D. K. Inflammatory bowel disease. N. Engl. J. Med. 347, 417–429 (2002).

    Article  CAS  Google Scholar 

  13. Mathew, C. G. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nature Rev. Genet. 9, 9–14 (2008).

    Article  CAS  Google Scholar 

  14. Fritz, J. H., Ferrero, R. L., Philpott, D. J. & Girardin, S. E. Nod-like proteins in immunity, inflammation and disease. Nature Immunol. 7, 1250–1257 (2006).

    Article  CAS  Google Scholar 

  15. Chamaillard, M. et al. Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl Acad. Sci. USA 100, 3455–3460 (2003).

    Article  CAS  Google Scholar 

  16. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603–606 (2001).

    Article  CAS  Google Scholar 

  17. Neurath, M. F. IL-23: a master regulator in Crohn disease. Nature Med. 13, 26–28 (2007).

    Article  CAS  Google Scholar 

  18. Xavier, R. J. & Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427–434 (2007).

    Article  CAS  Google Scholar 

  19. Rioux, J. D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nature Genet. 39, 596–604 (2007).

    Article  CAS  Google Scholar 

  20. Singh, S. B., Davis, A. S., Taylor, G. A. & Deretic, V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438–1441 (2006).

    Article  CAS  Google Scholar 

  21. Economou, M., Trikalinos, T. A., Loizou, K. T., Tsianos, E. V. & Ioannidis, J. P. A. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am. J. Gastroenterol. 99, 2393–2404 (2004).

    Article  CAS  Google Scholar 

  22. Tremelling, M. et al. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132, 1657–1664 (2007).

    Article  CAS  Google Scholar 

  23. Stratton, M. R. & Rahman, N. The emerging landscape of breast cancer susceptibility. Nature Genet. 40, 17–22 (2008).

    Article  CAS  Google Scholar 

  24. Barrett, J. C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nature Genet. 40, 955–962 (2008).

    Article  CAS  Google Scholar 

  25. Goh, K. I. et al. The human disease network. Proc. Natl Acad. Sci. USA 104, 8685–8690 (2007).

    Article  CAS  Google Scholar 

  26. Wray, N. R., Goddard, M. E. & Visscher, P. M. Prediction of individual genetic risk of complex disease. Curr. Opin. Genet. Dev. 18, 257–263 (2008).

    Article  CAS  Google Scholar 

  27. Pharoah, P. D. P. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nature Genet. 31, 33–36 (2002).

    Article  CAS  Google Scholar 

  28. Khoury, M. J., Yang, Q., Gwinn, M., Little, J. & Flanders, W. D. An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet. Med. 6, 38–47 (2004).

    Article  Google Scholar 

  29. Harlaar, N., Butcher, L., Meaburn, E., Craig, I. W. & Plomin, R. A behavioural genomic analysis of DNA markers associated with general cognitive ability in 7-year-olds. J. Child Psychol. Psychiatry 46, 1097–1107 (2005).

    Article  Google Scholar 

  30. Morrison, A. C. et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 166, 28–35 (2007).

    Article  Google Scholar 

  31. The International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).

  32. Pharoah, P. D. et al. Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet. 3, e42 (2007).

    Article  Google Scholar 

  33. Bare, L. A. et al. Five common gene variants identify elevated genetic risk for coronary heart disease. Genet. Med. 9, 682–689 (2007).

    Article  CAS  Google Scholar 

  34. Maller, J. et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nature Genet. 38, 1055–1059 (2006).

    Article  CAS  Google Scholar 

  35. van Hylckama Vlieg, A., Baglin, C. A., Bare, L. A., Rosendaal, F. R. & Baglin, T. P. Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis. J. Thromb. Haemost. 6, 751–754 (2008).

    Article  CAS  Google Scholar 

  36. Lyssenko, V. et al. Genetic prediction of future type 2 diabetes. PLoS Med. 2, e345 (2005).

    Article  Google Scholar 

  37. Nettle, D. The evolution of personality variation in humans and other animals. Am. Psychol. 61, 622–631 (2006).

    Article  Google Scholar 

  38. Kitano, H. Systems biology: a brief overview. Science 295, 1662–1664 (2002).

    Article  CAS  Google Scholar 

  39. Potkin, S. G. et al. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn. Neuropsychiatry 14, 391–418 (2009).

    Article  Google Scholar 

  40. Haworth, C. M. A. et al. Internet cognitive testing of large samples needed in genetic research. Twin Res. Hum. Genet. 10, 554–563 (2007).

    Article  Google Scholar 

  41. Bilder, R. M. et al. Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience 164, 30–42 (2009).

    Article  CAS  Google Scholar 

  42. Freimer, N. & Sabatti, C. The human phenome project. Nature Genet. 34, 15–21 (2003).

    Article  CAS  Google Scholar 

  43. Walley, A. J., Asher, J. E. & Froguel, P. The genetic contribution to non-syndromic human obesity. Nature Rev. Genet. 10, 431–442 (2009).

    Article  CAS  Google Scholar 

  44. First, M. B. et al. Clinical utility as a criterion for revising psychiatric diagnoses. Am. J. Psychiatry 161, 946–954 (2004).

    Article  Google Scholar 

  45. The Psychiatric GWAS Consortium Steering Committee. A framework for interpreting genome-wide association studies of psychiatric disorders. Mol. Psychiatry 14, 10–17 (2009).

  46. Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B. & Richardson, W. S. Evidence based medicine: what it is and what it isn't. BMJ 312, 71–72 (1996).

    Article  CAS  Google Scholar 

  47. Rose, G., Khaw, K. T. & Marmot, M. Rose's Strategy of Preventive Medicine (Oxford Univ. Press, 2008).

    Book  Google Scholar 

  48. Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889–894 (2007).

    Article  CAS  Google Scholar 

  49. Sladek, R., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881–885 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The preparation of this paper was supported in part by grants from the UK Medical Research Council (G050079), the Wellcome Trust (WT084728) and the US National Institute of Child Health and Human Development (HD44454). C.M.A.H. is supported by a Medical Research Council/Economic and Social Research Council Interdisciplinary Fellowship (G0802681). O.S.P.D. is supported by a Sir Henry Wellcome Fellowship (WT088984). We thank C. G. Mathew for comments on an earlier draft.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Plomin.

Related links

Related links

FURTHER INFORMATION

Nature Reviews Genetics series on Genome-Wide Association Studies

Glossary

Autophagy

The degradation by a cell of its own components. In the immune response, autophagy removes intracellular bacteria and viruses, and enhances adaptive immunity.

Case–control study

Compares cases (a selected group of individuals, for example, those diagnosed with a disorder) with controls (a comparison group of individuals, for example, those who are not diagnosed with the disorder). Genome-wide association case–control studies test whether genetic marker allele frequencies differ between cases and controls.

Comorbidity

The co-occurrence of two or more disorders or diseases in an individual.

Covariance

A statistic that indicates the extent to which two variables are related and vary together.

Crohn's disease

Characterized by chronic intestinal inflammation, which leads to diarrhoea, bleeding, severe abdominal pain and weight loss.

Effect size

The proportion of individual differences for a trait in the population that are accounted for by a particular factor.

Genome-wide association research

A hypothesis-free genetic method that uses hundreds of thousands of DNA markers distributed throughout the chromosomes to identify alleles that are correlated with a trait.

Heritability

The proportion of phenotypic variance in a population that is due to genetic variation.

Linear regression

A statistical method for testing and describing the linear relationship between variables. The regression coefficient describes the slope of the regression line and reflects the amount of variance of the dependent variable that is explained by variation of the independent variable.

Logistic regression

A statistical method for testing and describing the linear relationship between variables when the dependent variable is binary. It relates the log odds of the probability of an event to a linear combination of the predictor variables.

Odds ratio

A measurement of the effect size of an association for binary values. For example, in case–control studies, the odds ratio is calculated as the odds of an allele in cases divided by the odds of the allele in controls. An odds ratio of one indicates that there is no difference in allele frequency between cases and controls.

Pleiotropy

The effect of a single gene on multiple phenotypes.

Population cohort study

A longitudinal study of individuals who are representative of the general population and who are often recruited by their year of birth.

Power

The probability that a statistical test will reject the null hypothesis when the alternative hypothesis is true.

Quantitative genetics

A theory of multiple gene influences that, together with environmental variation, results in quantitative (continuous) distributions of phenotypes. Quantitative genetic methods, such as twin and adoption methods for human analysis, estimate genetic and environmental contributions to phenotypic variance and covariance in a population.

Sensitivity

The proportion of true positives that are accurately identified as such — for example, the percentage of cases that are diagnosed using a questionnaire. A sensitivity of 100% means that all cases are correctly identified.

Specificity

The proportion of true negatives that are classified as negatives. For example, a diagnostic test with specificity of 100% means that all healthy people have been identified as healthy.

Trait

A phenotype that differs between individuals in a species and shows some stability across time and situations. Disorders and diseases are qualitative (dichotomous) traits; quantitative traits are continuously distributed, usually as the bell-shaped curve called the normal distribution.

Variance

A measure of the dispersal of phenotypic scores around the mean.

Web-based testing

Administering online questionnaires and tests using the internet, which allows access to large and geographically diverse samples.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plomin, R., Haworth, C. & Davis, O. Common disorders are quantitative traits. Nat Rev Genet 10, 872–878 (2009). https://doi.org/10.1038/nrg2670

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrg2670

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing